3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Neuroendocrine Tumors
1
Breast Neoplasms
1
Interventions
lutetium Lu 177 dotatate
5
Data Collection
3
telotristat ethyl
2
Somatostatin
2
Positron-Emission Tomography
2
Magnetic Resonance Spectroscopy
2
Everolimus
2
Drug Therapy
2
Biopsy
2
surufatinib
1
lanreotide
1
copper dotatate CU-64
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sorafenib
1
Salvage Therapy
1
Radionuclide Imaging
1
Radiomics
1
Radiofrequency Ablation
1
Quality of Life
1
Plastic Surgery Procedures
1
Phlebotomy
1
Patient Reported Outcome Measures
1
Octreotide
1
Molecular Diagnostic Techniques
1
Lutetium-177
1
Lutetium
1
Liver Transplantation
1
Laparoscopy
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neuroendocrine Tumors
×
89Zr-bevacizumab
×
Clear all
NCT01338090
2012-04-03
NETPET
University Medical Center Groningen
Completed
14 enrolled